echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The fourth batch of 158 products to be selected: injection price reduction hit!

    The fourth batch of 158 products to be selected: injection price reduction hit!

    • Last Update: 2021-02-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network February 4th, February 3rd, the fourth batch of national drug centralized volume procurement in Shanghai officially opened the bid, 45 varieties of 8 injection varieties, 3 eye drops, the others are oral dosage form.
    , according to the latest news from Xinhua News Agency, this centralized procurement of a total of 158 products to be selected.
    the proposed average price reduction of 52%, the highest reduction of 96%, the preliminary estimate of the fourth batch of drugs is expected to save 12.4 billion yuan a year.
    the three previous batches of national mining, the average price reduction of the drugs covered is 54%, saving more than 53 billion yuan per year.
    industry had expected an average decline of more than 50%, especially for the eight injectable products, its competition and price trends will further affect the future market pattern.
    Injection price war curtain opened is worth noting that a total of 8 injection varieties were selected in this round of national extraction, namely, acetaminophen injection, propofol medium-long-chain fat milk, ibuprofen injection, doso-tea-alkali injection, Parexib injection, fentanyl injection, boratezomi injection and injection bival reed.
    meters intranet data show that the above eight injection products are clinical varieties, 8 products in 2019 sample hospital revenue accounted for 45 varieties in 2019 total sample hospital revenue of more than 30%, especially pythola injections, with annual sales of more than 6 billion yuan has attracted market attention.
    December 25, 2020, Shanghai Sunshine Pharmaceutical Procurement Network officially issued the Notice on the Collection of Information on the Central Procurement of Drugs by the Fourth Batch of State Organizations, marking the official launch of the fourth batch of national drug centralized procurement.
    industry analysis, due to the latest batch of national harvest more "barefooters" into the market, sub-sectors for further competition for market share, it is expected that several injection varieties of bidding will be more intense.
    from the national quotation site situation can be seen, ammonia bromoso injections and Parexib injections more participating enterprises, multinational enterprises original research products and many local pharmaceutical companies imitation products with the competition.
    with the promotion of injection consistency evaluation, the market competition situation in the future sub-sectors will be further intensified.
    The fourth batch of national injection varieties involved in the enterprise situation variety name specification quoted enterprise ammonia bromoso injection 1 ml: 7.5mg Yunnan Longhai, Sichuan Meida Kang Huakang Pharmaceuticals, Shandong Hualu, Chengdu Bert, Koren, Hua zhong, Jiangsu Coast, QingYuTang, Kang Enbei One magenta, Shandong Luoxin, Shijiazhuang four drugs, Hainan All-Star, Bollinger Ingeham, Hebei Kaiwei, Guorui Pharmaceuticals 2ml:15mg4ml:30mg propofol medium/long chain fat milk injection 20ml:0.2g Fessen Yuscabi, Yangzijiang, Jiangsu Yingke, Koren, Belang blofen injection 4ml:0.4g Hangzhou Minsheng, four-ring medicine, Chengdu Beit, Yuandong Bio 8ml:0.8g doso-tea base injection 10ml:0.1g Yangzijiang, Shijiazhuang Four Drugs, Anhui Star, Zhejiang Beisheng Pharmaceuticals Hansheng Pharmaceuticals, Garden Pharmaceuticals, Shanxi Noshing, ABC Farmaceutici S.P.A20ml: 0.2g Parexib Injection 20mg Aoya/Hongguan, Shandong Luoxin, Emeishan Tonghui, Chengdu Baiyu, Yangzijiang, Zhejiang Hangkang, Chengdu Yuandong, Zhengda Tianqing, Osaikang, Shanghai New Yellow River / Wanbang Bio-Chemical, Nanjing Shenghe, Hengrui, Colum, Haizheng, Pfizer, Qilu, 40mg 40mg Ofo Radrazo injections China Resources Shuanghe, East China, Chengdu Baiyu, Osaikang, Tongde Pharmaceuticals, Yangzijiang, Four Rings Medicine, Takeda Boratezomi Injection 1mg Zhengda Qing, Shi Medicine Oyi, Qilu, Howson, Yangsen 3.5mg injection than the reed 0.25g Qilu, Hainan Puli, Hainan Shuangcheng, The Medicines Company from the national quotation site news shows that the price of injection products is fierce, to ibuprofen injection, for example, 4 ml Ibuprofen injection maximum effective declared price of 57.6 yuan / branch, and Hangzhou Minsheng, four ring medicine, Chengdu Bate, Yuandong biological quotations are basically around 20 yuan, the lowest price even dropped to less than 15 yuan, and the market price before the price reduction generally exceeds 100 yuan.
    According to public information, the four-ring medicine ibuprofen injection in this collection has won the bid, in addition, Colum Pharmaceuticals' amin bromoso injections, propofol medium/ long-chain fat milk injections, Parexib injections 3 injection varieties are winning the bid;
    pressure on multinational enterprises has increased sharply with the continuous promotion of national and local volume procurement, price reduction has become a choice that pharmaceutical companies are not allowed to make.
    after the previous three rounds of centralized volume procurement, and local pharmaceutical companies actively participate in the national collection contrast, multinational enterprises for the volume of procurement attitude is still relatively cold, price adjustment is quite "symbolic."
    From the spot outflow of the winning bid price, to treat pain after surgery injection with Parexib sodium, for example, the variety 40mg maximum effective declared price of 93.9 yuan, after the difference, Emeishan Tonghui quote 2.98 yuan, and Pfizer original research varieties of the price of more than 80 yuan out.
    oral preparations also present a similar situation, to the degreeloxitin intestinal capsules, for example, the variety 20mg maximum effective declared price of 3.95 yuan, after the difference, Qingdao Baiyang quoted 0.275 yuan, while Lilly original research varieties reported a high price of about 9 yuan to be eliminated.
    In addition, Johnson and Johnson's Caglie net tablets (Ikea), Bayer's chloretamine tablets (Kairretan) and toluene sulfonate tablets (Dojime), Novarma's salutane chloride tablets (Pebot) and pyridine hydrochloride tablets (Fudaiwen), Pfizer's Volicon tablets (Viven) and other branded products, are in this national production.
    industry experts believe that in the past, multinational enterprises brand products enjoy the advantages of the original drug pricing, drug profits are higher, the sale of sanjia hospital alone can obtain huge profits, the first-tier city public medical institutions by multinational pharmaceutical companies as the core market, with the evaluation of generic drug consistency, the market competitiveness of the original drug is gradually weakened.
    fact, under the background of the reform of the medical insurance payment system, the traditional customer visit and cost-driven sales model is urgently facing the transformation.
    recently, multinational companies such as AstraZeneta, Pfizer, Bayer, Lilly and Sanofi have made multiple rounds of optimization and adjustments to their sales teams to address and mitigate the impact of volume purchases on the product market.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.